MKS Inc. $MKSI is SummitTX Capital L.P.’s 5th Largest Position

SummitTX Capital L.P. lowered its holdings in MKS Inc. (NASDAQ:MKSI) by 21.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 160,909 shares of the scientific and technical instruments company’s stock after selling 44,841 shares during the period. MKS makes up 1.2% of SummitTX Capital L.P.’s holdings, making the stock its 5th biggest holding. SummitTX Capital L.P.’s holdings in MKS were worth $36,978,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of MKS by 3.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after acquiring an additional 9,170 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of MKS by 63.4% in the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after acquiring an additional 325 shares in the last quarter. First Trust Advisors LP boosted its holdings in MKS by 3,545.6% in the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock valued at $14,036,000 after purchasing an additional 137,392 shares during the period. Cerity Partners LLC purchased a new position in MKS in the second quarter valued at $1,676,000. Finally, AXA S.A. grew its stake in MKS by 22.8% during the 2nd quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after purchasing an additional 5,430 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at MKS

In related news, EVP David Philip Henry sold 2,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $330.50, for a total value of $826,250.00. Following the completion of the transaction, the executive vice president directly owned 16,341 shares of the company’s stock, valued at $5,400,700.50. This represents a 13.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ramakumar Mayampurath sold 8,810 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $315.48, for a total transaction of $2,779,378.80. Following the completion of the transaction, the chief financial officer owned 1 shares in the company, valued at $315.48. This represents a 99.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 53,949 shares of company stock valued at $17,446,108 over the last three months. 0.57% of the stock is owned by corporate insiders.

MKS Stock Performance

NASDAQ:MKSI opened at $329.18 on Monday. MKS Inc. has a 12 month low of $88.49 and a 12 month high of $447.62. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.11 and a quick ratio of 0.70. The firm has a market capitalization of $22.23 billion, a PE ratio of 68.87, a price-to-earnings-growth ratio of 0.94 and a beta of 1.93. The business’s fifty day moving average price is $351.31 and its 200 day moving average price is $282.14.

MKS (NASDAQ:MKSI) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.00 by $0.30. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. MKS had a return on equity of 21.49% and a net margin of 8.06%.MKS’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.71 EPS. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, sell-side analysts anticipate that MKS Inc. will post 11.77 earnings per share for the current fiscal year.

MKS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Wednesday, June 3rd were paid a dividend of $0.25 per share. The ex-dividend date was Wednesday, June 3rd. This represents a $1.00 annualized dividend and a yield of 0.3%. MKS’s payout ratio is presently 20.92%.

Analyst Upgrades and Downgrades

MKSI has been the topic of several recent research reports. Needham & Company LLC upped their price target on MKS from $300.00 to $360.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Morgan Stanley boosted their price objective on MKS from $374.00 to $442.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Bank of America upped their target price on shares of MKS from $380.00 to $500.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of MKS in a report on Friday, July 17th. Finally, JPMorgan Chase & Co. lifted their price target on shares of MKS from $305.00 to $365.00 and gave the stock an “overweight” rating in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, MKS currently has a consensus rating of “Moderate Buy” and an average target price of $385.00.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.